Arrhythmias and electrophysiology focus on understanding the electrical activities of the heart and their role in maintaining a regular heartbeat. Advanced mapping techniques and ablation therapies have revolutionized the treatment of conditions like atrial fibrillation and ventricular tachycardia. Electrophysiology studies provide critical insights into identifying arrhythmic triggers and pathways, enabling precise interventions. Innovations such as leadless pacemakers and implantable cardioverter defibrillators (ICDs) have enhanced the management of life-threatening arrhythmias. Researchers are also delving into the genetic basis of arrhythmias, aiming to develop personalized therapeutic strategies. This domain continues to evolve, offering hope for improved quality of life and reduced mortality rates for patients with rhythm disorders.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain